Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics
Collaboration will leverage Atavistik Bio’s proprietary AMPS™ platform to rapidly identify and validate novel allosteric ...
Pfizer, Atavistik to collaborate on allosteric drug discovery
Pfizer (PFE) has entered into a collaborative research agreement with Atavistik Bio for the discovery of novel precision allosteric therapeutics. Read more here.
Pfizer Joins Forces with Atavistik Bio to Unlock Revolutionary Cancer Treatments
This partnership could redefine precision medicine with groundbreaking therapeutics targeting "impossible" proteins.
Atavistik Bio, Pfizer Collaborate To Accelerate Discovery Of Novel Precision Allosteric Therapeutics
Biotechnology company Atavistik Bio announced Thursday that it has entered into a research collaboration with Pfizer, Inc. (PFE) to ...
Pharmabiz5d
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics
Atavistik Bio enters research collaboration with Pfizer to accelerate discovery of novel precision allosteric therapeutics: Cambridge, Massachusetts Friday, January 3, 2025, 15:00 ...
Nasdaq6d
Atavistik Bio, Pfizer Collaborate To Accelerate Discovery Of Novel Precision Allosteric Therapeutics
(RTTNews) - Biotechnology company Atavistik Bio announced Thursday that it has entered into a research collaboration with Pfizer, Inc. (PFE) to accelerate the discovery of novel precision ...